|
US4853221A
(en)
|
1980-11-13 |
1989-08-01 |
Warner-Lambert Company |
Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
|
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US5294430A
(en)
|
1988-09-12 |
1994-03-15 |
University Of Rochester |
Use of dithiocarbamates to treat myelosuppression
|
|
US5035878A
(en)
|
1988-09-12 |
1991-07-30 |
University Of Rochester |
Use of dithiocarbamates to counteract myelosuppression
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5597798A
(en)
|
1990-03-05 |
1997-01-28 |
The Regents Of The University Of California |
Taxol and epidermal growth factor used to enhance treatment of ovarian cancer
|
|
ES2187500T3
(es)
|
1991-02-21 |
2003-06-16 |
Smithkline Beecham Corp |
Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas.
|
|
US6287792B1
(en)
|
1991-06-17 |
2001-09-11 |
The Regents Of The University Of California |
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
|
|
US5795870A
(en)
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
|
EP0758549A4
(en)
|
1994-04-26 |
1997-07-02 |
Nobuhiro Narita |
MEDICAL COMPOSITION AS A MEDICINE FOR NON-SMALL CELL CANCER
|
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
|
CA2293674A1
(en)
|
1997-06-04 |
1998-12-10 |
Egbert Bakker |
A diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination
|
|
US6335156B1
(en)
|
1997-12-18 |
2002-01-01 |
The Johns Hopkins University School Of Medicine |
14-3-3σ arrests the cell cycle
|
|
CA2319495A1
(en)
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
ATE315392T1
(de)
|
1998-07-09 |
2006-02-15 |
Francis A Nardella |
Zusammensetzungen zur behandlung chronischer lymphatischer leukämie
|
|
WO2001007084A1
(en)
|
1999-07-23 |
2001-02-01 |
Regents Of The University Of California |
Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery
|
|
US6635677B2
(en)
|
1999-08-13 |
2003-10-21 |
Case Western Reserve University |
Methoxyamine combinations in the treatment of cancer
|
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
US20020037328A1
(en)
*
|
2000-06-01 |
2002-03-28 |
Brown Dennis M. |
Hexitol compositions and uses thereof
|
|
GB0014820D0
(en)
|
2000-06-16 |
2000-08-09 |
Medical Res Council |
Methods and materials relating to plasmid vectors
|
|
ITMI20002358A1
(it)
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
|
WO2003000012A2
(en)
|
2001-06-21 |
2003-01-03 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
|
|
EP2138575B8
(en)
|
2002-02-20 |
2013-07-24 |
Mersana Therapeutics, Inc. |
Conjugates comprising a biodegradable polymer and uses therefor
|
|
US7910314B2
(en)
|
2002-03-01 |
2011-03-22 |
Roger Williams Hospital |
Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
|
|
CA2480176A1
(en)
|
2002-04-11 |
2003-10-23 |
Zymogenetics, Inc. |
Use of interleukin-24 to treat ovarian cancer
|
|
JP2005529101A
(ja)
|
2002-04-11 |
2005-09-29 |
ザイモジェネティクス インコーポレイティッド |
卵巣癌を治療するためのインターロイキン−１９の使用法
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
WO2004064748A2
(en)
|
2003-01-21 |
2004-08-05 |
Trustees Of Dartmouth College |
Compositions and methods for treatment of ovarian cancer
|
|
WO2004085505A2
(en)
|
2003-03-24 |
2004-10-07 |
Sequoia Pharmaceuticals, Inc. |
Long acting biologically active conjugates
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
JP4851933B2
(ja)
|
2003-04-11 |
2012-01-11 |
ピーティーシー セラピューティクス，インコーポレーテッド |
１，２，４−オキサジアゾール安息香酸化合物ならびにナンセンス抑制及び疾患の治療のためのその使用
|
|
KR20060088102A
(ko)
|
2003-09-04 |
2006-08-03 |
아벤티스 파마슈티칼스 인크. |
폴리(ａｄｐ-리보스)폴리머라제(ｐａｒｐ)의 억제제로서의치환된 인돌
|
|
JP2007507524A
(ja)
|
2003-10-02 |
2007-03-29 |
セフアロン・インコーポレーテツド |
インドール誘導体
|
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
|
AU2004289539C1
(en)
|
2003-11-14 |
2012-06-07 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
DK1725528T3
(da)
|
2004-03-11 |
2013-09-02 |
4Sc Ag |
Sulfonylpyrroler som hdac-inhibitorer
|
|
WO2005099824A1
(en)
|
2004-03-30 |
2005-10-27 |
Synta Pharmaceuticals, Corp. |
1-glyoxylamide indolizines for treating lung and ovarian cancer
|
|
WO2005098446A2
(en)
|
2004-03-31 |
2005-10-20 |
The Johns Hopkins University |
Biomarkers for ovarian cancer
|
|
WO2006001967A2
(en)
|
2004-05-25 |
2006-01-05 |
Sloan-Kettering Institute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
|
ATE498613T1
(de)
|
2004-06-30 |
2011-03-15 |
Janssen Pharmaceutica Nv |
Chinazolinonderivate als parp-hemmer
|
|
ES2440990T5
(es)
|
2004-07-22 |
2022-10-25 |
Univ Erasmus Med Ct Rotterdam |
Moléculas de unión
|
|
CA2580719C
(en)
|
2004-08-20 |
2013-10-22 |
Buck Institute For Age Research |
Small molecules that replace or agonize p53 function
|
|
CA2579810C
(en)
|
2004-09-17 |
2012-01-24 |
Eisai R&D Management Co., Ltd. |
Stable pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide
|
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
WO2006058088A2
(en)
|
2004-11-23 |
2006-06-01 |
Ptc Therapeutics, Inc. |
Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
|
|
AU2005316652B2
(en)
|
2004-12-15 |
2009-07-23 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Combinations of therapeutic agents for treating cancer
|
|
MX2007008771A
(es)
|
2005-01-19 |
2007-09-11 |
Mgi Gp Inc |
Compuestos de diazabenzo [des] antracen-3-ona y metodos para inhibir parp.
|
|
WO2006081158A2
(en)
|
2005-01-25 |
2006-08-03 |
The Regents Of The University Of California |
Predictive and therapeutic markers in overian cancer
|
|
EP1702989A1
(en)
|
2005-03-16 |
2006-09-20 |
Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon |
Method of predicting the clinical response to cisplatin or carboplatin chemotherapeutic treatment
|
|
US7728026B2
(en)
|
2005-04-11 |
2010-06-01 |
Abbott Laboratories, Inc. |
2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
|
|
UA95775C2
(uk)
|
2005-04-26 |
2011-09-12 |
Пфайзер Инк. |
Антитіло, яке специфічно зв'язується з р-кадгерином
|
|
AR053272A1
(es)
|
2005-05-11 |
2007-04-25 |
Hoffmann La Roche |
Determinacion de responsivos a la quimioterapia
|
|
JP5159616B2
(ja)
|
2005-06-15 |
2013-03-06 |
カーディオム ファーマ コーポレイション |
アミノシクロヘキシルエーテル化合物の調製のための合成プロセス
|
|
EP1910821B1
(en)
|
2005-06-24 |
2013-02-20 |
Ciphergen Biosystems, Inc. |
Biomarkers for ovarian cancer
|
|
JP2009501235A
(ja)
*
|
2005-07-15 |
2009-01-15 |
シェーリング コーポレイション |
癌処置において有用なキナゾリン誘導体
|
|
US8133692B2
(en)
|
2005-07-20 |
2012-03-13 |
University Of South Florida |
Methods of predicting responsiveness to chemotherapeutic agents and selecting treatments
|
|
US8101799B2
(en)
|
2005-07-21 |
2012-01-24 |
Ardea Biosciences |
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
|
|
JP5178515B2
(ja)
|
2005-08-12 |
2013-04-10 |
シンタ ファーマシューティカルズ コーポレーション |
Ｈｓｐ９０活性を調節するピラゾール化合物
|
|
US8124095B2
(en)
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
|
US7507536B2
(en)
|
2005-10-07 |
2009-03-24 |
The Johns Hopkins University |
Methylation markers for diagnosis and treatment of ovarian cancer
|
|
KR20080066039A
(ko)
|
2005-10-19 |
2008-07-15 |
추가이 세이야쿠 가부시키가이샤 |
신규 수용성 프로드러그를 함유하는 췌장암, 난소암 또는 간암의 예방 또는 치료제
|
|
US20090099102A1
(en)
|
2005-10-27 |
2009-04-16 |
The Brigham And Women's Hospital, Inc. |
Ginkgolides in the Treatment and Prevention of Ovarian Cancer
|
|
CA2629244C
(en)
|
2005-11-11 |
2014-08-05 |
Boehringer Ingelheim International Gmbh |
Quinazoline derivatives for the treatment of cancer diseases
|
|
DE602006015508D1
(de)
|
2005-11-16 |
2010-08-26 |
Pantarhei Bioscience Bv |
Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
|
|
ES2540561T3
(es)
|
2005-12-20 |
2015-07-10 |
Incyte Corporation |
N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
|
|
CA2634468C
(en)
|
2005-12-23 |
2014-10-07 |
Ecobiotics Limited |
Spiroketals
|
|
EP1986625B1
(en)
|
2006-02-10 |
2012-08-01 |
Ramot at Tel-Aviv University Ltd. |
Treatment of ovarian cancer
|
|
ES2422890T3
(es)
|
2006-03-17 |
2013-09-16 |
Ambit Biosciences Corporation |
Compuestos de imidazolotiazol para el tratamiento de enfermedades proliferativas
|
|
UA95799C2
(en)
|
2006-04-26 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Pharmaceutical compounds
|
|
US8768629B2
(en)
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
BRPI0711011A2
(pt)
|
2006-05-18 |
2011-08-23 |
Molecular Profiling Institute, Inc. |
método para a determinação da intervenção médica para um estado de doença, método para a identificação de uma terapia de droga com capacidade de interação com um alvo molecular e sistema para a determinação da intervenção médica individualizada para um estado de doença
|
|
CA2653222A1
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
US8034834B2
(en)
|
2006-05-25 |
2011-10-11 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders with HSP90 inhibitors
|
|
WO2007149907A2
(en)
|
2006-06-20 |
2007-12-27 |
Abbott Laboratories |
Pyrazoloquinazolinones as parp inhibitors
|
|
PL2061765T3
(pl)
|
2006-09-01 |
2015-04-30 |
Senhwa Biosciences Inc |
Modulatory białkowych kinaz serynowo-treoninowych i PARP
|
|
US7547781B2
(en)
|
2006-09-11 |
2009-06-16 |
Curis, Inc. |
Quinazoline based EGFR inhibitors containing a zinc binding moiety
|
|
WO2008044029A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
UY30639A1
(es)
|
2006-10-17 |
2008-05-31 |
Kudos Pharm Ltd |
Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
|
|
CN101678022A
(zh)
|
2006-12-21 |
2010-03-24 |
弗特克斯药品有限公司 |
可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物
|
|
US8168415B2
(en)
|
2007-02-07 |
2012-05-01 |
The Regents Of The University Of Colorado |
Axl fusion proteins as Axl tyrosine kinase inhibitors
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
DK2129396T3
(da)
|
2007-02-16 |
2013-11-25 |
Merrimack Pharmaceuticals Inc |
Antistoffer mod ErbB3 og anvendelser deraf
|
|
KR20090115879A
(ko)
|
2007-02-28 |
2009-11-09 |
이노텍 파마슈티컬스 코포레이션 |
인데노이소퀴놀리논 유사체와 이의 이용 방법
|
|
EP2899541A1
(en)
|
2007-03-02 |
2015-07-29 |
Genentech, Inc. |
Predicting response to a HER dimerisation inhbitor based on low HER3 expression
|
|
JP5545955B2
(ja)
|
2007-03-08 |
2014-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体
|
|
US8030060B2
(en)
|
2007-03-22 |
2011-10-04 |
West Virginia University |
Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer
|
|
MX2009010828A
(es)
|
2007-04-06 |
2009-10-29 |
Neurocrine Biosciences Inc |
Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos.
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
JP2008295328A
(ja)
|
2007-05-30 |
2008-12-11 |
Fujifilm Corp |
卵巣癌の検出方法、及び抑制方法
|
|
CN101678019B
(zh)
|
2007-06-08 |
2016-03-30 |
詹森药业有限公司 |
哌啶/哌嗪衍生物
|
|
KR20120087885A
(ko)
|
2007-06-29 |
2012-08-07 |
안국약품 주식회사 |
난소암의 예측 마커
|
|
US8981131B2
(en)
|
2007-07-27 |
2015-03-17 |
Piramal Enterprises Limited |
Tricyclic compounds for the treatment of inflammatory disorders
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
US8309573B2
(en)
|
2007-08-10 |
2012-11-13 |
Mitsubishi Tanabe Pharma Corporation |
Salt of isoquinoline compound and crystal thereof
|
|
CN101802226A
(zh)
|
2007-09-17 |
2010-08-11 |
皇家飞利浦电子股份有限公司 |
分析卵巢癌病症的方法
|
|
EP2842956A1
(en)
|
2007-10-03 |
2015-03-04 |
Eisai Inc. |
PARP inhibitor compounds, compositions and methods of use
|
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain Compounds, Compositions and Methods
|
|
CN101909630A
(zh)
|
2007-11-02 |
2010-12-08 |
新加坡科技研究局 |
预防和治疗肿瘤的方法和化合物
|
|
IL187247A0
(en)
|
2007-11-08 |
2008-12-29 |
Hadasit Med Res Service |
Novel synthetic analogs of sphingolipids
|
|
NZ586123A
(en)
|
2007-11-12 |
2012-12-21 |
Bipar Sciences Inc |
Treatment of ovarian cancer with 4-iodo-3-nitrobenzamide in combination with topoisomerase inhibitors
|
|
US20090170842A1
(en)
|
2007-11-14 |
2009-07-02 |
University Of Kansas |
Brca1-based breast or ovarian cancer prevention agents and methods of use
|
|
ES2524787T3
(es)
|
2007-11-15 |
2014-12-12 |
Msd Italia S.R.L. |
Derivados de piridazinona como inhibidores de PARP
|
|
CA2705952C
(en)
|
2007-11-23 |
2018-05-01 |
British Columbia Cancer Agency Branch |
Methods for detecting lung cancer and monitoring treatment response
|
|
WO2009075799A2
(en)
|
2007-12-05 |
2009-06-18 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
|
US8933212B2
(en)
|
2007-12-06 |
2015-01-13 |
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Use of protease nexin 1 inhibitors to reduce metastasis
|
|
US8741889B2
(en)
|
2008-01-11 |
2014-06-03 |
Hoffmann-La Roche Inc |
Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor
|
|
ES2494365T3
(es)
|
2008-01-30 |
2014-09-15 |
Genentech, Inc. |
Compuestos de pirazolopirimidina que inhiben PI3K y métodos de uso
|
|
US8642347B2
(en)
|
2008-01-31 |
2014-02-04 |
The Brigham And Women's Hospital, Inc. |
Urinary CA125 peptides as biomarkers of ovarian cancer
|
|
JP2011511078A
(ja)
|
2008-02-06 |
2011-04-07 |
レアド トヘラペウトイクス，インコーポレーテッド |
ポリ（ａｄｐリボース）ポリメラーゼ（ｐａｒｐ）のベンズオキサゾールカルボキサミド阻害剤
|
|
JP2011511076A
(ja)
|
2008-02-08 |
2011-04-07 |
エイルロン セラピューティクス，インコーポレイテッド |
治療用ペプチド模倣大環状分子
|
|
WO2009101639A1
(en)
|
2008-02-14 |
2009-08-20 |
Decode Genetics Ehf. |
Susceptibility variants for lung cancer
|
|
TWI441639B
(zh)
|
2008-02-20 |
2014-06-21 |
Actelion Pharmaceuticals Ltd |
用於治療卵巢癌之包含紫杉醇之組合
|
|
FR2928151B1
(fr)
|
2008-03-03 |
2010-12-31 |
Sanofi Aventis |
Derives platine-carbene n-heterocyclique, leur preparation et leur application en therapeutique
|
|
KR101601997B1
(ko)
|
2008-03-17 |
2016-03-17 |
암비트 바이오사이언시즈 코포레이션 |
Ｒａｆ 키나아제 조절제로서의 퀴나졸린 유도체 및 그의 사용방법
|
|
WO2009145815A2
(en)
|
2008-04-01 |
2009-12-03 |
The Brigham And Women's Hospital, Inc. |
Biomarkers of ovarian cancer
|
|
KR101626136B1
(ko)
|
2008-04-14 |
2016-06-03 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
플렉스트린 상동 도메인의 소분자 억제제 및 이의 사용방법
|
|
WO2009127619A1
(en)
|
2008-04-16 |
2009-10-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
|
|
CL2009001152A1
(es)
|
2008-05-13 |
2009-10-16 |
Array Biopharma Inc |
Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
|
|
WO2009137921A1
(en)
|
2008-05-14 |
2009-11-19 |
University Health Network |
Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
|
|
ES2529361T3
(es)
|
2008-06-11 |
2015-02-19 |
Genentech, Inc. |
Dicarbazoles y métodos de uso
|
|
HRP20130045T1
(hr)
|
2008-07-09 |
2013-02-28 |
Rigel Pharmaceuticals, Inc. |
Premošteni bicikliäśki heteroaril supstituirani triazoli koji su korisni kao axl inhibitori
|
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
|
US8338477B2
(en)
|
2008-07-11 |
2012-12-25 |
Neumedics |
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
|
|
LT2767537T
(lt)
|
2008-08-06 |
2017-08-10 |
Medivation Technologies, Inc. |
Poli(adp-ribozės)polimerazės (parp) dihidropiridoftalazinono inhibitoriai
|
|
WO2010017545A2
(en)
|
2008-08-08 |
2010-02-11 |
Synta Pharamceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
CA2732658A1
(en)
|
2008-08-15 |
2010-02-18 |
Merrimack Pharmaceuticals, Inc. |
Methods and systems for predicting response of cells to a therapeutic agent
|
|
EP2331547B1
(en)
|
2008-08-22 |
2014-07-30 |
Novartis AG |
Pyrrolopyrimidine compounds as cdk inhibitors
|
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
KR100961410B1
(ko)
|
2008-10-14 |
2010-06-09 |
(주)네오팜 |
단백질 키나제 억제제로서 헤테로사이클릭 화합물
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
US8946275B2
(en)
|
2008-10-21 |
2015-02-03 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer using hypoxia activated prodrugs
|
|
US8946289B2
(en)
|
2008-11-19 |
2015-02-03 |
Duke University |
Manassatin compounds and methods of making and using the same
|
|
HRP20130409T2
(hr)
|
2008-11-26 |
2013-11-22 |
Pfizer Inc. |
3-aminociklopentankarboksamidi kao modulatori kemokinskih receptora
|
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
US8058075B2
(en)
|
2008-12-10 |
2011-11-15 |
University Of Utah Research Foundation |
Molecular fluorescence sensor for highly sensitive and selective detection of mercury
|
|
EP2380024B1
(en)
|
2008-12-22 |
2014-06-11 |
Roche Diagnostics GmbH |
Armet as a marker for cancer
|
|
BRPI1007358A2
(pt)
|
2009-01-23 |
2018-03-06 |
Takeda Pharmaceutical Company Limited |
inibidores de poli (adp-ribose) polimerase (parp)
|
|
EP2396007A1
(en)
|
2009-02-10 |
2011-12-21 |
Celgene International Sarl |
Methods for treating non-small cell lung cancer using 5-azacytidine
|
|
US8648046B2
(en)
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
|
EP2401267B1
(en)
|
2009-02-27 |
2014-01-15 |
Ambit Biosciences Corporation |
Jak kinase modulating quinazoline derivatives and their use in methods
|
|
US8969001B2
(en)
|
2009-03-12 |
2015-03-03 |
Rush University Medical Center |
Materials and methods for predicting recurrence of non-small cell lung cancer
|
|
CN101869558A
(zh)
*
|
2009-04-22 |
2010-10-27 |
北京大学 |
二乙酰二脱水卫矛醇的抗血管生成及肿瘤转移作用
|
|
PT104607B
(pt)
|
2009-05-20 |
2012-03-23 |
Univ De Coimbra |
Derivados triterpenóides úteis como agentes antiproliferativos
|
|
ES2679379T3
(es)
|
2009-06-15 |
2018-08-24 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirimidinilpirrolopiridinona sustituidos, proceso para su preparación y su uso como inhibidores de cinasa
|
|
US8980268B2
(en)
|
2009-07-29 |
2015-03-17 |
Regeneron Pharamceuticals, Inc. |
Methods for treating cancer by administering an anti-Ang-2 antibody
|
|
WO2011014681A1
(en)
|
2009-07-30 |
2011-02-03 |
Takeda Pharmaceutical Company Limited |
Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
|
|
EP2460005A4
(en)
|
2009-07-31 |
2012-11-21 |
Translational Genomics Res Inst |
METHOD FOR ASSESSING A CANCER PROGRESSION RISK
|
|
EP2471791B1
(en)
|
2009-08-26 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic ring derivative and use thereof
|
|
US20130203861A1
(en)
|
2009-09-09 |
2013-08-08 |
Golden Biotechnology Corporation |
Methods and compositions for treating ovarian cancer
|
|
US20120183546A1
(en)
|
2009-09-23 |
2012-07-19 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
|
KR101449217B1
(ko)
|
2009-09-28 |
2014-10-08 |
에프. 호프만-라 로슈 아게 |
벤즈옥세핀 ｐｉ3ｋ 억제제 화합물 및 사용 방법
|
|
CN102548945A
(zh)
|
2009-10-08 |
2012-07-04 |
桑福德-伯纳姆医学研究院 |
作为抗癌剂的阿朴棉子酚酮衍生物
|
|
WO2011042217A1
(en)
|
2009-10-09 |
2011-04-14 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
JP2013517281A
(ja)
|
2010-01-13 |
2013-05-16 |
テンペロ、ファーマシューティカルズ、インコーポレイテッド |
化合物及び方法
|
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
|
JP5972176B2
(ja)
|
2010-02-23 |
2016-08-17 |
サノフイ |
抗アルファ２インテグリン抗体及びそれらの使用
|
|
EP2548017A2
(en)
|
2010-03-15 |
2013-01-23 |
Genus Oncology, Llc |
Small molecule inhibitors of muc1 and methods of identifying the same
|
|
WO2011117668A1
(en)
|
2010-03-22 |
2011-09-29 |
Council Of Scientific & Industrial Research |
Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
|
|
CA2797468C
(en)
|
2010-04-27 |
2018-04-24 |
Pharma Mar, S.A. |
Anticancer steroidal lactones unsaturated in position 7 (8)
|
|
WO2011138409A1
(en)
|
2010-05-05 |
2011-11-10 |
Universität Bayreuth |
Combretastatin analogs for use in the treatment of cancer
|
|
CN103003424B
(zh)
|
2010-05-18 |
2015-05-13 |
株式会社医学生物学研究所 |
结合转化生长因子α且对Ras基因突变的癌具有增殖抑制活性的抗体
|
|
DK2918588T3
(en)
|
2010-05-20 |
2017-08-28 |
Array Biopharma Inc |
Macrocyclic compounds as TRK kinase inhibitors
|
|
CN105061438B
(zh)
|
2010-06-23 |
2017-07-04 |
韩美科学株式会社 |
用于抑制酪氨酸激酶活性的稠合嘧啶衍生物
|
|
US8962679B2
(en)
|
2010-07-08 |
2015-02-24 |
The Administrators Of The Tulane Educational Fund |
Daidzein analogs as treatment for cancer
|
|
ES2552841T3
(es)
|
2010-07-12 |
2015-12-02 |
Bayer Intellectual Property Gmbh |
Imidazo[1,2-a]pirimidinas y -piridinas sustituidas
|
|
GB201012105D0
(en)
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
US20120171694A1
(en)
|
2010-07-30 |
2012-07-05 |
Vermillion, Inc. |
Predictive markers and biomarker panels for ovarian cancer
|
|
US8987267B2
(en)
|
2010-08-05 |
2015-03-24 |
Temple University—Of the Commonwealth System of Higher Education |
2-substituted-8-alkyl-7-OXO-7,8-dihydropyrido[2,3-D]pyrimidine-6-carbonitriles and uses thereof in treating proliferative disorders
|
|
EP3246026A3
(en)
*
|
2010-08-18 |
2018-02-21 |
Del Mar Pharmaceuticals |
Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
|
|
US8471026B2
(en)
|
2010-08-26 |
2013-06-25 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
|
WO2012030685A2
(en)
|
2010-09-01 |
2012-03-08 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
|
US8975260B2
(en)
|
2010-09-01 |
2015-03-10 |
Genetech, Inc |
Pyridazinones, method of making, and method of use thereof
|
|
WO2012030896A2
(en)
|
2010-09-01 |
2012-03-08 |
Arqule, Inc. |
Methods for treatment of non-small cell lung cancer
|
|
US8980955B2
(en)
|
2010-09-17 |
2015-03-17 |
Indiana University Research And Technology |
Small molecule inhibitors of replication protein A that also act synergistically with cisplatin
|
|
WO2012047570A1
(en)
|
2010-09-28 |
2012-04-12 |
Schering Corporation |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
|
KR101497113B1
(ko)
|
2010-10-20 |
2015-03-03 |
한국생명공학연구원 |
Ｈｉｆ-1 활성을 저해하는 아릴옥시페녹시아크릴계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
EA201370107A1
(ru)
|
2010-11-11 |
2013-11-29 |
Редкс Фарма Лимитед |
Производные лекарственных средств
|
|
EP2638395A4
(en)
|
2010-11-12 |
2016-06-01 |
Endocyte Inc |
METHOD FOR TREATING CARCINOMA
|
|
AR083916A1
(es)
|
2010-11-18 |
2013-04-10 |
Takeda Pharmaceutical |
Metodo para tratar el cancer de mama y cancer de ovarios
|
|
EP2646430B1
(en)
|
2010-12-03 |
2016-09-21 |
Emory University |
Chemokine cxcr4 receptor modulators and uses related thereto
|
|
US8927560B2
(en)
|
2010-12-06 |
2015-01-06 |
Council Of Scientific & Industrial Research |
4-Aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
|
|
MY164910A
(en)
|
2010-12-16 |
2018-02-15 |
Hoffmann La Roche |
Tricyclic pi3k inhibitor compounds and methods of use
|
|
JP5883457B2
(ja)
|
2010-12-17 |
2016-03-15 |
アール リチャードソン，デ |
チオセミカルバゾン化合物および癌の治療における使用
|
|
WO2012096832A2
(en)
|
2011-01-12 |
2012-07-19 |
Crystal Biopharmaceutical Llc |
Hdac inhibiting derivatives of camptothecin
|
|
EP2668190B1
(en)
|
2011-01-26 |
2016-08-17 |
Nerviano Medical Sciences S.r.l. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
|
US8946409B2
(en)
|
2011-01-27 |
2015-02-03 |
Board Of Regents, The University Of Texas System |
Polycyclic β lactam derivatives for the treatment of cancer
|
|
US8987257B2
(en)
|
2011-01-31 |
2015-03-24 |
Novartis Ag |
Heterocyclic derivatives
|
|
EP2678021A4
(en)
|
2011-02-24 |
2015-07-01 |
Jiangsu Hansoh Pharmaceutical |
PHOSPHORUS COMPOUNDS AS A PROTEIN KINASE INHIBITOR
|
|
CA2828119A1
(en)
|
2011-02-24 |
2012-08-30 |
Vermillion, Inc. |
Biomarker panels, diagnostic methods and test kits for ovarian cancer
|
|
WO2012116328A2
(en)
|
2011-02-24 |
2012-08-30 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
|
|
ES2951688T3
(es)
|
2011-02-28 |
2023-10-24 |
Epizyme Inc |
Compuestos de heteroarilo biciclico fusionados en 6,5 sustituidos
|
|
ES2569185T3
(es)
|
2011-03-01 |
2016-05-09 |
Nucana Biomed Limited |
Derivados de fosforamidato de 5-fluoro-2'-desoxiuridina para uso en el tratamiento del cáncer
|
|
EP2908132B8
(en)
|
2011-03-02 |
2019-06-12 |
Nestec S.A. |
Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures
|
|
CA2828889A1
(en)
|
2011-03-04 |
2012-09-13 |
New York University |
Hydrogen bond surrogate macrocycles as modulators of ras
|
|
US8748470B2
(en)
|
2011-03-17 |
2014-06-10 |
The University Of Chicago |
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins
|
|
US20140357605A1
(en)
|
2012-03-22 |
2014-12-04 |
Bristol-Myers Squibb Company |
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
|
|
WO2012138537A1
(en)
|
2011-04-01 |
2012-10-11 |
Immunogen, Inc. |
Compositions and methods for treatment of ovarian, peritoneal, and fallopian tube cancer
|
|
WO2012138678A1
(en)
|
2011-04-04 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
Gamma secretase inhibitors
|
|
KR101974673B1
(ko)
|
2011-06-24 |
2019-05-02 |
아르퀼 인코포레이티드 |
치환된 이미다조피리디닐-아미노피리딘 화합물
|
|
CN105198862B
(zh)
|
2011-07-27 |
2018-01-23 |
阿斯利康(瑞典)有限公司 |
取代的n‑(4‑氟‑2‑甲氧基‑5‑硝基苯基)嘧啶‑2‑胺化合物及其盐
|
|
US9499530B2
(en)
|
2011-08-01 |
2016-11-22 |
Hangzhou Minsheng Institutes For Pharma Research |
Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
|
|
WO2013020062A1
(en)
|
2011-08-04 |
2013-02-07 |
Array Biopharma Inc. |
Quinazoline compounds as serine/threonine kinase inhibitors
|
|
US9045450B2
(en)
|
2011-08-10 |
2015-06-02 |
Zhen Yang |
Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer
|
|
DE102011112978A1
(de)
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
|
JP6053795B2
(ja)
|
2011-09-19 |
2016-12-27 |
シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ |
強力なｈｄａｃ阻害剤としてのラクタムを有する新しいチオ誘導体、及び治療剤としてのその使用
|
|
WO2013043255A1
(en)
|
2011-09-21 |
2013-03-28 |
University Of South Alabama |
Methods and compositions for the treatment of ovarian cancer
|
|
AU2012312305B2
(en)
|
2011-09-22 |
2016-11-17 |
Merck Sharp & Dohme Corp. |
Acyclic cyanoethylpyrazoles as janus kinase inhibitors
|
|
EP2771337B1
(en)
|
2011-09-27 |
2017-08-02 |
Novartis AG |
3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh
|
|
SI2760860T1
(sl)
|
2011-09-28 |
2017-04-26 |
Euro-Celtique S.A. |
Derivati dušikove gorčice
|
|
WO2013053045A1
(en)
|
2011-10-12 |
2013-04-18 |
Beta Pharma Canada Inc. |
Heterocyclic molecules as apoptosis inducers
|
|
US8940737B2
(en)
|
2011-10-14 |
2015-01-27 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
WO2013062943A1
(en)
|
2011-10-24 |
2013-05-02 |
Glaxosmithkline Intellectual Property Development Limited |
New compounds
|
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
HK1201733A1
(en)
|
2011-11-03 |
2015-09-11 |
Millennium Pharmaceuticals, Inc. |
Administration of nedd8-activating enzyme inhibitor and hypomethylating agent
|
|
CN104024255B
(zh)
|
2011-11-03 |
2017-01-18 |
霍夫曼-拉罗奇有限公司 |
作为btk活性的抑制剂的烷基化哌嗪化合物
|
|
CN104185631A
(zh)
|
2011-11-10 |
2014-12-03 |
纪念斯隆-凯特琳癌症中心 |
用2-氨基-4H-萘并[1,2-b]吡喃-3-甲腈治疗卵巢癌
|
|
WO2013071001A1
(en)
|
2011-11-10 |
2013-05-16 |
Memorial Sloan-Kettering Cancer Center |
Treatment of ovarian cancer with benzylidenebenzohydrazides
|
|
BR112014011197A2
(pt)
|
2011-11-11 |
2017-04-25 |
Lilly Co Eli |
terapia combinada para o câncer ovariano
|
|
KR20140097402A
(ko)
|
2011-11-22 |
2014-08-06 |
데시페라 파마슈티칼스, 엘엘씨. |
항암 및 항증식 활성을 나타내는 피리돈 아미드 및 유사체
|
|
WO2013096755A1
(en)
|
2011-12-21 |
2013-06-27 |
New York University |
Proteolytically resistant hydrogen bond surrogate helices
|
|
EP2802586B1
(en)
|
2012-01-10 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Substituted imidazopyrazines as akt kinase inhibitors
|
|
US20150087600A1
(en)
|
2012-01-19 |
2015-03-26 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
US10201521B2
(en)
*
|
2012-01-20 |
2019-02-12 |
Del Mar Pharmaceuticals (Bc) Ltd. |
Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma
|
|
JP6006241B2
(ja)
|
2012-01-31 |
2016-10-12 |
第一三共株式会社 |
ピリドン誘導体
|
|
AR092790A1
(es)
|
2012-02-01 |
2015-05-06 |
Euro Celtique Sa |
Derivados bencimidazolicos del acido hidroxamico
|
|
MX347772B
(es)
|
2012-03-06 |
2017-05-12 |
Cephalon Inc |
Derivado de 2,4-diaminopirimidina biciclico fusionado como un inhibidor dual de alk y fak.
|
|
US9266828B2
(en)
|
2012-03-16 |
2016-02-23 |
Sanford-Burnham Medical Research Institute |
Inhibitors of Furin and other pro-protein convertases
|
|
ES2641864T3
(es)
|
2012-03-20 |
2017-11-14 |
Novartis Ag |
Terapia de combinación de un inhibidor de MEK y un inhibidor de IGF1R
|
|
US10280168B2
(en)
|
2012-03-30 |
2019-05-07 |
Agency For Science, Technology And Research |
Bicyclic heteroaryl derivatives as MNK1 and MNK2 modulators and uses thereof
|
|
JP6192708B2
(ja)
|
2012-03-30 |
2017-09-06 |
ライゼン・ファーマシューティカルズ・エスアー |
Ｃ−ｍｅｔプロテインキナーゼ調節物質としての新規３，５−二置換−３ｈ−イミダゾ［４，５−ｂ］ピリジン化合物および３，５−二置換−３ｈ−［１，２，３］トリアゾロ［４，５−ｂ］ピリジン化合物
|
|
US9809858B2
(en)
|
2012-04-05 |
2017-11-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
O-glycan pathway ovarian cancer signature
|
|
EP2836482B1
(en)
|
2012-04-10 |
2019-12-25 |
The Regents of The University of California |
Compositions and methods for treating cancer
|
|
MX2014013751A
(es)
|
2012-05-11 |
2015-08-07 |
Abbvie Inc |
Piridazina y derivados de piridina como inhibidores de nampt.
|
|
WO2013181462A1
(en)
|
2012-05-31 |
2013-12-05 |
Amgen Inc. |
Use of amg 900 for the treatment of cancer
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US8980934B2
(en)
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
BR112014032346A2
(pt)
*
|
2012-06-26 |
2017-06-27 |
Del Mar Pharmaceuticals |
métodos para tratamento de malignidades resistentes ao inibidor de tirosina-quinase em pacientes com polimorfismos genéticos ou desregulações de ahi1 mutações empregando dianidrogalactitol, diacetildianidrogalactitol, dibromodulcitol, ou análogos ou derivados destes
|
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
|
WO2014078295A1
(en)
|
2012-11-13 |
2014-05-22 |
BoYen Therapeutics, Inc. |
Gemcitabine prodrugs and uses thereof
|
|
AR093445A1
(es)
|
2012-11-14 |
2015-06-10 |
Regeneron Pharma |
Metodos para tratar el cancer de ovario con antagonistas de dll4
|
|
US8946246B2
(en)
|
2012-11-16 |
2015-02-03 |
New Mexico Technical Research Foundation |
Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
|
|
MX2015007205A
(es)
|
2012-12-06 |
2016-03-31 |
Quanticel Pharmaceuticals Inc |
Inhibidores de la desmetilasa de histona.
|
|
MX373639B
(es)
|
2012-12-20 |
2020-05-04 |
Merck Sharp & Dohme |
Imidazopiridinas sustituidas como inhibidores de doble minuto 2 humana.
|
|
KR20150100814A
(ko)
|
2012-12-21 |
2015-09-02 |
콴티셀 파마슈티컬스, 인크. |
히스톤 데메틸라제 억제제
|
|
US8940726B2
(en)
|
2012-12-21 |
2015-01-27 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
|
PT2956173T
(pt)
|
2013-02-14 |
2017-06-26 |
Bristol Myers Squibb Co |
Compostos de tubulisina, métodos de produção e utilização
|
|
US8980879B2
(en)
|
2013-03-11 |
2015-03-17 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
CA2901929A1
(en)
|
2013-03-13 |
2014-10-02 |
Abbvie Inc. |
Cdk9 kinase inhibitors
|
|
WO2014143241A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
US8969360B2
(en)
|
2013-03-15 |
2015-03-03 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
US10413538B2
(en)
|
2013-05-08 |
2019-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer
|
|
US20140371158A1
(en)
|
2013-06-14 |
2014-12-18 |
Georgia Regents University |
Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway
|
|
AU2014100435A4
(en)
|
2013-06-17 |
2014-05-29 |
Macau University Of Science And Technology |
A novel treatment of Gefitinib-resistant non-small-cell lung cancer
|
|
MX2015018038A
(es)
|
2013-07-03 |
2016-03-16 |
Hoffmann La Roche |
Compuestos de heteroaril-piridona y aza-piridona-amida.
|
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
|
US9278978B2
(en)
|
2013-08-23 |
2016-03-08 |
Boehringer Ingelheim International Gmbh |
6-Alkynyl Pyridine
|
|
US9249151B2
(en)
|
2013-08-23 |
2016-02-02 |
Boehringer Ingelheim International Gmbh |
Bis-amido pyridines
|
|
US20150065526A1
(en)
|
2013-09-05 |
2015-03-05 |
Emory University |
Overcoming acquired resistance to chemotherapy treatments through suppression of stat3
|
|
US8927717B1
(en)
|
2014-02-14 |
2015-01-06 |
National Defense Medical Center |
Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
|